Language : English
Published : 2015-08-31
Pages : 1280
Biochemistry and Molecular Biology of Plants 2nd Edition
Biochemistry and Molecular Biology of Plants, 2nd Edition has been hailed as a major contribution to the plant sciences literature and critical acclaim has been matched by global sales success. Maintaining the scope and focus of the first edition, the second will provide a major update, include much new material and reorganise some chapters to further improve the presentation. This book is meticulously organised and richly illustrated, having over 1,000 full-colour illustrations and 500 photographs. It is divided into five parts covering: Compartments, Cell Reproduction, Energy Flow, Metabolic and Developmental Integration, and Plant Environment and Agriculture. Specific changes to this edition include: * Completely revised with over half of the chapters having a major rewrite. * Includes two new chapters on signal transduction and responses to pathogens. * Restructuring of section on cell reproduction for improved presentation. * Dedicated website to include all illustrative material. Biochemistry and Molecular Biology of Plants holds a unique place in the plant sciences literature as it provides the only comprehensive, authoritative, integrated single volume book in this essential field of study.
About the Author
EDITED BY Bob B. Buchanan, University of California, Berkeley, USA Wilhelm Gruissem, ETH Zurich, Switzerland Russell L. Jones, University of California, Berkeley, USA
Transportation systems and vehicles play an important role in modern life. They would not be possible without fuel. This handbook gives a comprehensive overview of various types of fuels used to power vehicles of all kinds and the processes to produce these fuels. The main focus is on automotive fuels, however, aviation and marine fuels are described as well as alternative and novel fuels, such as ethanol, methanol, natural gas and others.
The book is not only valuable for students and graduated scientists from various industries like oil and automobile companies, but also for journalists interested in this field.
About the Author
Barbara Elvers studied chemistry at the University of Hamburg from 1970 to 1979 where she received her PhD in carbohydrate chemistry. After working in a research project in biochemistry at the university hospital in Hamburg she moved to the United States of America in 1980 where she was employed as a visiting scientist at SRI, Palo Alto, in the life science department. She started working for VCH in 1985, first as a freelance translator of textbooks in chemistry, and from 1987 onwards as an editor of Ullmann’s Encyclopedia. One of the main subjects of her editorial work was the acquisition of authors and articles in the field of energy generation and fuels. Dr. Elvers has been living in Hamburg since 1996, working as an editor for Ullmann’s and other reference works and for the Wiley-VCH journal Starch/Stärke.
Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry with an emphasis on emerging topics in the biological sciences that are expected to provide the basis for entirely new future therapies. * Reviews on hot topics of interest in small molecule drug discovery heavily pursued by industrial research organizations* Provides preclinical information in the context of chemical structures* Knowledgeable section editors who evaluate invited reviews for scientific rigor
About the Author
Dr. Manoj Desai began his career in the pharmaceutical industry at Pfizer Inc, Central Research Division, Groton, CT (1986-1994) before moving to Chiron Corporation (1994-2003) as Director of medicinal chemistry; he was promoted to Vice President, lead discovery and medicinal chemistry (2000). In October 2003, he was appointed Vice President of medicinal chemistry at Gilead Sciences. At Pfizer, he was responsible for the medicinal chemistry efforts that lead to the discovery of oral Substance P antagonist CP-99994 which became the basis for the discovery of the new anti-emetics. At Chiron he formulated macrobead technology for the synthesis and screening of compound libraries for HTS and built the medicinal chemistry department with focus on kinase inhibitors. At Gilead, he was an active proponent to develop a pharmacoenhancer devoid of antiviral activity to improve the pharmacokinetics of integrase inhibitor elvitegravir. These efforts led to the discovery of Cobicistat which is one of components of StribildTM that was approved by FDA in August 2012 for the treatment of HIV infection. He is co-inventor on patents of Cobicistat (US 8,148,374), StribildTM and Ledipasvir (US 8,273,341; Phase III). Furthermore, his group at Gilead has advanced numerous compounds into clinical development for the treatment of antiviral diseases, cancer and cardiovascular diseases. Dr. Desai obtained Ph.D. in organic chemistry from the M.S. University of Baroda in 1981 working with Dr. Sukh Dev and then carried out post-doctoral fellowships at Purdue University working with Professor Herbert C. Brown (19981-1983) and at Harvard University with Professor Elias J. Corey (1983-1986). During his postdoctoral studies, he worked on natural product isolation, development of asymmetric synthetic methods using organoboranes and total synthesis of complex natural products such as retigeranic acid, ?-trans bergamotene and ginkgolide B. He has co-authored >60 publications in peer reviewed journals and is an inventor on >25 issued patents. Furthermore, Dr. Desai is Editor-in-Chief for Annual Reports in Medicinal chemistry (2012-current), and have co-edited Comprehensive Medicinal Chemistry II (volume 7). In 2013, he co-edited book titled “Successful Strategies for the Discovery of Antiviral Drugs .
This Cengage Technology Edition is the result of an innovative and collaborative development process. The textbook retains the hallmark approach of this respected text, whilst presenting the content in a print and digital hybrid that has been tailored to meet the rapidly developing demands of today’s lecturers and students. This blended solution offers a streamlined textbook for greater accessibility and convenience, complemented by a bolstered online presence, for a truly multi-faceted learning experience. This market-leading text, known for its carefully-developed, thoroughly-integrated, step-by-step approach to problem-solving helps students to master quantitative skills and build a lasting conceptual understanding of key chemical concepts. General Chemistry presents up-to-date coverage of the latest developments and standards in chemistry.
This book, the fourth in a series of Understanding Chemistry books, deals with Basic Chemistry.
Written for students taking either the University of Cambridge O-level examinations or the GCSE examinations, this textbook covers essential topics under both stipulated chemistry syllabi. The book is written in such a way as to guide the reader through the understanding and applications of basic essential chemical concepts by introducing a discourse feature — the asking and answering of questions — that stimulates coherent thinking and hence, elucidates ideas. Based on the Socratic Method, questions are implanted throughout the book to help facilitate the reader’s development in forming logical conclusions of concepts. The book helps students to master fundamental chemical concepts in a simple way.
Readership: O level students and teaching professionals in Chemistry.